Breakthrough experimental vaccine shows early success against rare pediatric liver cancer
A new experimental cancer vaccine developed by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy has delivered highly encouraging early results for a rare and aggressive form of liver cancer that mainly affects children and…
